Financial statements 2R Pharma Consultants W Likwidacji
Balance sheet of 2R Pharma Consultants W Likwidacji
Share capital:
Share capital:
60 000 PLN
Company deleted from KRS: 2025-01-28
Balance sheet data of 2R PHARMA CONSULTANTS W LIKWIDACJI
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 60 108,62 | 35 149,83 | 36 192,78 | 32 808,09 | 7 623,44 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 60 108,62 | 35 149,83 | 36 192,78 | 32 808,09 | 7 623,44 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 60 108,62 | 35 149,83 | 36 192,78 | 32 808,09 | 7 623,44 |
| A. Equity | -74 180,52 | -99 574,36 | -101 577,69 | -110 087,26 | -132 282,70 |
| B. Liabilities and provisions for liabilities | 134 289,14 | 134 724,19 | 137 770,47 | 142 895,35 | 139 906,14 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 133 820,07 | 134 724,19 | 137 770,47 | 142 895,35 | 139 906,14 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.